AddedRisk Factors
The OHCA CMIR has the potential to delay or prevent proposed transactions and require disclosure of confidential information.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedRisk Factors
The California OHCA CMIR process may delay, and potentially ultimately prevent, the closing of certain proposed transactions. If a CMIR results in a negative finding and generates a referral to the California Attorney General, that could result in the parties not being able to conclude the proposed transaction and possibly require the subject facilities to appoint new managers. Any delay or prevention of completing transactions could have adverse effect on the operations of our independent subsidiaries. The risk of an adverse regulatory outcome, competitive harm, or potential legal action will persist until the CMIR is successfully concluded.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedRisk Factors
The CMIR process also seeks the disclosure of confidential information regarding our independent subsidiaries’ reimbursement rates and financial performance. This information is subject to contractual confidentiality obligations and otherwise proprietary to our business and is likewise a source of competitive advantage in the marketplace. If this information is disclosed to, or otherwise obtained by OHCA, we anticipate that it will be publicly available and could provide competitors with otherwise unavailable data on the financial operations and reimbursement relationships of our independent subsidiaries.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedRisk Factors
We have filed a Petition in the Superior Court of the State of California, County of Orange, seeking a declaration that the CMIR regulations violate the United States Constitution and/or the California Constitution, and is void and unenforceable as applied to us. We have requested that OHCA be ordered to withdraw the subpoena and close the inquiry, so the underlying transaction can be completed.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RemovedRisk Factors
•Federal minimum staffing mandates may adversely affect our labor costs, ability to maintain desired levels of patient or resident capacity, and profitability.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
•The condition of the financial markets could limit the availability of debt and equity financing sources to fund the capital and liquidity requirements of our business.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
You should carefully consider each of the following risk factors. The risk factors generally have been separated into two categories: risks relating to our business and our industry and risks relating to our common stock. Based on the information currently known to us, we believe that the following information identifies the most significant risk factors affecting our company in each of these categories of risks. However, the risks and uncertainties we face are not limited to those set forth in the risk factors described below. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. In addition, past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
If any of the following risks and uncertainties develops into actual events, these events could have a material adverse effect on our business, financial condition or results of operations. In such case, the trading price of our common stock could decline. You should carefully read the following risk factors, together with the financial statements, related notes and other information contained in this Annual Report on Form 10-K. This Annual Report on Form 10-K contains forward-looking statements that contain risks and uncertainties. Please refer to the section entitled "Cautionary Note Regarding Forward-Looking Statements" on page [1] of this Annual Report on Form 10-K in connection with your consideration of the risk factors and other important factors that may affect future results described below.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
•changes in staff requirements as a condition of payment or eligibility for Medicare reimbursement (See also, Item 1., under Government Regulation);
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
•state-specified and potential federal mandates for specific nurse staffing levels;
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
Federal minimum staffing mandates may adversely affect our labor costs, ability to maintain desired levels of patient or resident capacity, and profitability.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
On April 22, 2024, CMS issued the Staffing Rule, establishing minimum staffing standards for SNFs. As discussed in more detail in Item 1., under Government Regulation, the Staffing Rule contains three primary staffing requirements which are phased in over the next several years. Due to pending legislation in both the House of Representatives and the Senate, industry litigation filed to dispute the Staffing Rule's validity and enforceability, as well as the long phase-in of the Staffing Rule's requirements, the exact effects of the Staffing Rule cannot yet be ascertained. Given the pending legislation before both houses of Congress, change in control of the Presidency, changes in leadership of HHS and CMS, and change in control of the Senate following the 2024 presidential election, future developments may significantly alter or even halt the implementation of the Staffing Rule. However, we expect that the Staffing Rule in its current form will have adverse financial consequences upon our business unless or until it is repealed, enjoined, or otherwise prevented from taking effect.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
We may be required to hire substantially more staff members, particularly nurse practitioners, registered nurses, and nursing aides than currently staffed. Additionally, the Staffing Rule would place similar pressure on our competitors and result in sudden, expanded demand for nursing staff across the SNF industry. This sudden demand across the SNF industry may exacerbate an already difficult labor market, with demand for nursing staff far outstripping the supply of qualified individuals, and the salary requirements of both current and prospective staff increasing markedly to increase the likelihood of recruiting and retaining skilled caregivers.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
Effective October 2024, California law SB525 increased the minimum wage for healthcare workers. However, the law will only impact SNFs upon passage of a companion bill imposing minimum direct spending requirements upon SNFs. For the 2023-2024 California legislative session, this minimum spending bill took the form of AB1537 and, as of October 2024 has been placed in suspense without further action. A future bill may still be passed that would trigger SB525's requirements for healthcare workers in SNFs to receive higher minimum wages. As discussed in Item 1., Government Regulation, these proposed bills would create new and costly obligations on our independent subsidiaries if they became law and if enacted, would adversely affect our business, operations, and profitability.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
The condition of the financial markets, including volatility and deterioration in the capital and credit markets, could limit the availability of debt and equity financing sources to fund the capital and liquidity requirements of our business, as well as negatively impact or impair the value of our current portfolio of cash, cash equivalents and investments, including U.S. Treasury securities and U.S.-backed investments.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedRisk Factors
Our cash, cash equivalents and investments are held in a variety of interest-bearing instruments, including U.S. treasury securities. As a result of the uncertain domestic and global political, economic, credit and financial market conditions, including the increases in the federal funds rate since 2021, with limited decreases in 2024, and Consumer Price Index increases above historical norms for 2024, investments in these types of financial instruments pose risks arising from liquidity and credit concerns. Given that future deterioration in the U.S. and global credit and financial markets is a possibility, no assurance can be made that losses or significant deterioration in the fair value of our cash, cash equivalents, or investments will not occur. Uncertainty surrounding the trading market for U.S. government securities or impairment of the U.S. government's ability to satisfy its obligations under such treasury securities could impact the liquidity or valuation of our current portfolio of cash, cash equivalents, and investments, a substantial portion of which were invested in U.S. treasury securities. Further, continued domestic and international political uncertainty, along with credit, and financial market uncertainty, may make it difficult for us to liquidate our investments prior to their maturity without incurring a loss, which would have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RewordedRisk Factors
If we are not able Absent some judicial or legislative intervention, or other ability to secure pre-admission arbitration agreements, potentially resolve claims without the cost and unpredictability of a jury trial (for example, obtaining a jury trial waiver if and where permitted by state law), our litigation exposure and costs of defense in patient liability actions could increase, our liability insurance premiums could increase, and our business may be adversely affected.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
As a result of the 2024 presidential election, changes in the Presidency The current Presidential administration and both houses control of Congress may result in significant changes in, and by the President's political party have resulted in changes that have caused, and will continue to cause, uncertainty with respect to, to legislation, regulation, implementation or repeal of laws and rules related to government health programs, including Medicare and Medicaid.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
While it is not possible to predict whether and when any such changes will occur, specific proposals discussed during and after made by the election, current Administration or others in anticipation of mid-term elections in the U.S., including a repeal or material amendment of the ACA ACA, potential cuts to the Medicare or Medicaid programs by Congress through the budget reconciliation process, or other laws affecting the provision of healthcare services, could harm our business, operating results and financial condition.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
The outcome of the 2024 presidential election, including change in control of the Senate and Presidency from the Democratic to the Republican party, current Presidential Administration may result in a reversal reverse some of these orders, cause significant changes in HHS and CMS policy and rulemaking, and a reduced reduce the likelihood of successful legislation that seeks to provide more resources to creating pathways to care-based careers.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
The SNF PPS FY 2025 Final Rule implemented increased PPS introduced higher penalties that surveyors may can impose on SNFs for perceived non-compliance if they are found to be non-compliant with CMS’s requirements for SNF participation in Medicare. Medicare program.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
Additionally, CMS's recently finalized rule requiring disclosure of ownership and financial relationships between nursing facilities and property owners or management entities, which now carries new requirements for re-certification that have been delayed in implementation and may take effect at a future, yet-unknown date, as well as other state rules over ownership transparency, may provide an additional basis for further investigation, administrative action, and ultimately fines, penalties, or sanctions and could dissuade individuals and businesses from doing business with us or our independent subsidiaries.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
Additionally, CMS issued its the 42 CFR Part 2 final rule issued in 2024 updating the separate confidentiality requirements for Substance Use Disorder substance use disorder (SUD) records maintained. requires compliance by February 16 ,2026.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, in 2023, CMS updated the survey resources that and guidelines used both by CMS and state surveyors use in evaluating our SNFs’ compliance with federal Requirements for Participation, incorporating recent changes to CMS’s methods for surveying infection control procedures. participation requirements.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
The ACA continues to be a salient political topic and proposed changes to it may become the subject of campaign promises, litigation, administrative action, or legislation following under the 2024 presidential election. current Presidential Administration, and the Senate, where the Republican party now holds a majority of seats.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
Such Any future cost-containment measures and ongoing payment changes could will likely have an adverse effect on our revenue. revenue, whether positively or negatively depending on the trend of rulemakings going forward.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
Certain results of the Biden-Harris Administration’s rulemaking, including enhanced enforcement ability, may be retained under the new current Presidential Administration. Administration, as signaled by its recent decision to prohibit pre-dispute agreements to arbitrate disputes in SNF admission agreements.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedRisk Factors
These enhanced penalties and enforcement activities precedes greater focus by CMS in obtaining oversight over SFFs, and continuing that oversight even after those SFFs improve, improve as recommended by the OIG in its October 24, 2025 report and recommendations regarding the SFF program, and subjecting them to more exacting and routine oversight.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
We currently have no facilities one facility placed on SFF status.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
In November of 2023, OIG added to its work plan an audit of nursing homes' nurse staffing hours reported in CMS's payroll-based journal, for which OIG expects expected to issue a report in FY 2025.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
If we fail to comply with applicable environmental laws, we would will face increased expenditures in terms of fines and remediation of the underlying problems, potential litigation relating to exposure to such materials, and a potential decrease in value to our business and in the value of our underlying assets.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedMD&A
Insignia Pathway - In November 2025, we donated $10.0 million to Insignia Pathway, a non-profit organization formed in 2024 with a mission to empower, support and expand the post-acute care workforce. Insignia Pathway is dedicated to inspiring the current and next generation to choose careers in this essential field. In its first year of operation, the charity awarded over $1.0 million in grants to Registered Nurses from 23 countries who have committed to work for U.S.-based skilled nursing providers. In total, we have donated $45.0 million to Insignia Pathway since its formation.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedMD&A
Litigation — During the year ended December 31, 2025, we agreed to settle all alleged wage, hour or labor code-related violations asserted on a class or representative basis against our independent subsidiaries in California for purported violations occurring during the six year period ending December 2025, for $12.0 million, pending court approval.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedMD&A
(2) Represents gains on the sale of investments that are not part of our core business operations. These investments have no observable market prices and are held at historical cost basis until sold or impaired.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedMD&A
(2) Represents gains on the sale of investments that are not part of our core business operations. These investments have no observable market prices and are held at historical cost basis until sold or impaired.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
AddedMD&A
Our average Medicaid rates increased 4.6% due to state reimbursement increases, our participation in Medicaid supplemental payment and quality improvement programs in various states.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RemovedMD&A
Insignia Pathway — In December 2024, we funded $35.0 million to the formation of Insignia Pathway, an independent public charity, with a mission to empower, support and expand the post acute care workforce through recruiting talent, providing resources, education, housing and advocacy to enhance professional growth, job satisfaction and community impact. Insignia Pathway is dedicated to addressing workforce challenges, fostering equity and inspiring the current and next generation to join the essential field of post acute care. Insignia Pathway is currently in the process of applying for recognition of exemption as an organization under Section 501(c)(3) of the Internal Revenue Code.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RemovedMD&A
Our average Medicaid rates increased 8.3% due to state reimbursement increases, our participation in supplemental Medicaid payment programs and quality improvement programs in various states and changes in Medicaid mix. For example, we continue to have an increase in Medicaid days in states with higher rates, such as California. In addition, during the COVID periods from 2020 through 2023, we received state relief funding through Medicaid programs from various states such as California. These funds have been excluded from our average daily rates from 2020-2023. Starting in 2024, several of the states we operate in have incorporated the state relief funding as part of the state per diem rates or enhanced their supplemental programs. As results, these revenue are included in the 2024 average daily revenue rate. As such, the increase in Medicaid rates from 2023 to 2024 is not a lateral comparison.
Read it in 10-K Feb 5, 2025 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 2024 2023 Change % Change TRANSITIONING SAME FACILITY RESULTS:(3) RESULTS:(2)(5) (Dollars in thousands) Skilled services revenue $ 507,143 3,424,421 $ 472,808 3,214,896 $ 34,335 7.3% 209,525 6.5% Number of facilities at period end 40 40 210 210 — —% Number of campuses at period end(1) 1 1 25 25 — —% Actual patient days 1,336,074 1,302,680 33,394 2.6% 7,579,892 7,382,176 197,716 2.7% Occupancy percentage — Operational beds 76.0 82.9 % 73.0 80.9 % 3.0 2.0 % 4.1% 2.5% Skilled mix by nursing days 21.8 32.3 % 20.7 31.1 % 1.1 1.2 % 5.3% 3.9% Skilled mix by nursing revenue 38.4 51.2 % 38.4 49.5 % — 1.7 % —% 3.4%
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 2024 2023 Change % Change TRANSITIONING FACILITY RESULTS:(3) (Dollars in thousands) Skilled services revenue $ 507,143 760,325 $ 472,808 697,529 $ 34,335 7.3% 62,796 9.0% Number of facilities at period end 40 40 48 48 — —% Number of campuses at period end(1) 1 1 2 2 — —% Actual patient days 1,336,074 1,302,680 33,394 2.6% 1,703,570 1,639,695 63,875 3.9% Occupancy percentage — Operational beds 76.0 84.2 % 73.0 80.8 % 3.0 3.4 % 4.1% 4.2% Skilled mix by nursing days 21.8 29.6 % 20.7 27.8 % 1.1 1.8 % 5.3% 6.5% Skilled mix by nursing revenue 38.4 50.8 % 38.4 48.6 % — 2.2 % —% 4.5%
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
(In thousands) Income before provision for income taxes $ 455,622 $ 386,094 $ 272,762 Stock-based compensation expense 48,299 36,226 30,767 Litigation(1) 12,000 (1,425) 60,781 Loss (gain) on long-lived assets and gain (Gain) loss on business interruption recoveries and long-lived assets, net (3,285) 2,335 (1,132) Gain on other investments(2) (2,437) — Acquisition related costs(2) costs(3) 2,211 1,019 814 Costs incurred related to system implementations 2,430 2,953 963 Depreciation and amortization - patient base(3) base(4) 1,020 574 355 Interest expense - write off deferred financing fees(4) fees(5) — 200 — ADJUSTED EBT $ 515,860 $ 427,976 $ 365,310
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
The $29.5 $217.1 million decrease increase in cash provided by operating activities for the year ended December 31, 2024 2025 compared to the same period in 2023 2024 was due to payment an increase in operational performance and timing of the $48.0 million related to the litigation matter discussed in Item 3., Legal Proceedings payments and we funded $35.0 million to Insignia Pathway, which is discussed in Recent Activities. accounts receivable collections.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
The $1.6 $9.6 million increase in cash provided used by financing activities for the year ended December 31, 2024 2025 compared to the same period in 2023, 2024, was primarily due to $20.0 million of share repurchases in 2025 as part of our stock option exercises repurchase program offset by an increase in cash provided by the purchase issuance of non-controlling interest in one of our ancillary businesses. stock options.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
Operational and New State Expansions — During the year ended December 31, 2024, 2025, we expanded our operations with the addition of 28 40 stand-alone skilled nursing operations, five stand-alone senior living operations and three one campus operations, which added a total of 3,030 operational skilled nursing beds and 218 operational senior living units to be operated by our independent subsidiaries. operation.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
Stock-based compensation expense 48,299 36,226 30,767 Litigation(1) 12,000 (1,425) 60,781 Loss (gain) on long-lived assets and gain (Gain) loss on business interruption recoveries and long-lived assets, net (3,285) 2,335 (1,132) Gain on other investments(2) (2,437) — Acquisition related costs(2) costs(3) 2,211 1,019 814 Costs incurred related to system implementations 2,430 2,953 963 ADJUSTED EBITDA $ 602,350 $ 490,392 $ 425,762 Rent—cost of services 239,312 216,016 197,358 ADJUSTED EBITDAR $ 706,408 841,662
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
Operational and New State Expansions — During the year ended December 31, 2024, we expanded our These new operations with the addition of 28 stand-alone skilled nursing operations and three campus operations, which added a total of 3,030 4,175 operational skilled nursing beds and 218 313 operational senior living units to be operated by our independent subsidiaries.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
Subsequent to December 31, 2024, 2025, Standard Bearer added $50.9 approximately $18.1 million of real estate associated with four two stand-alone skilled nursing operations and one campus operation. operations, as discussed above, where all of the stand-alone skilled nursing facilities were leased back to our independent subsidiaries.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
We continued to see a shift in grow our Medicare patient population from Medicare in addition to managed care as capturing market share in the increases in Medicare Advantage enrollment continues to account for a larger portion enrollments of the overall Medicare eligible population.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
A discussion of our cash flows for the year ended December 31, 2022 is included in Part II, Item 7, Management’s Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources, included in our Annual Report on Form 10-K for the year ended December 31, 2023 2024 filed with the Securities and Exchange Commission on February 1, 2024. 5, 2025.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new
RewordedMD&A
Cash paid to fund acquisitions was $323.3 million for the year ended December 31, 2025 compared to $156.5 million for the year ended December 31, 2024 compared to cash paid of $69.0 million for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 4, 2026 at sec.govopen_in_new